TipRanks
Go Ultimate55% OFF

ProKidney (PROK) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PROK Analyst Ratings

Moderate Buy
6Ratings
3Buy2Hold1Sell
Based on 6 analysts giving stock ratings to ProKidney in the past 3 months

PROK Stock 12 Month Forecast

MXN 116.51▲(368.67% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for ProKidney in the last 3 months. The average price target is MXN 116.51 with a high forecast of MXN 225.50 and a low forecast of MXN 18.79. The average price target represents a 368.67% change from the last price of MXN 24.86.
Highest Price TargetMXN 225.50Average Price TargetMXN 116.51Lowest Price TargetMXN 18.79

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:PROK
Price TargetFollowArticle
H.C. WainwrightMXN 225.50buy807.10%UpsideReiterated10/28/26
CitiMXN 187.92→MXN 150.34buy504.73%UpsideReiterated10/28/26
Bank of America SecuritiesMXN 18.79sell-24.41%DownsideReiterated10/27/26
J.P. Morgan―hold―Reiterated08/13/26
Morgan StanleyMXN 56.38hold126.77%UpsideReiterated08/11/26
Guggenheim Analyst forecast on MX:PROKUnknown AnalystNot RankedGuggenheimMXN 131.54buy429.14%UpsideReiterated08/10/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ProKidney

3 Months
Success Rate1/6 ratings generated profit
17%
Average Return
-14.30%

Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -14.30% per trade.

1 Year
Success Rate1/6 ratings generated profit
17%
Average Return
-31.72%

Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -31.72% per trade.

2 Years
Success Rate1/6 ratings generated profit
17%
Average Return
-25.60%

Copying Yigal Nochomovitz's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -25.60% per trade.

PROK Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for PROK
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy22242
Buy00000
Hold12220
Sell11132
Strong Sell00000
total45594

In the current month, PROK has received 2 Buy Ratings, 0 Hold Ratings, and 2 Sell Ratings. PROK average Analyst price target in the past 3 months is 116.51.

PROK Financial Forecast

MXN -6MXN -5MXN -4MXN -3MXN -2Q4 2025Q2 2026Q3 2026
HighMXN -2.25
ConsensusMXN -2.97
LowMXN -4.65

PROK Earnings Forecast

Next quarter’s earnings estimate for PROK is -MXN 2.97 with a range of -MXN 4.65 to -MXN 2.25. The previous quarter’s EPS was -MXN 2.79. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN -1MXN 1MMXN 2.1MMXN 3.1MMXN 4.2MQ4 2025Q2 2026Q3 2026
HighMXN 3.72M
ConsensusMXN 2.32M
LowMXN 0.00

PROK Sales Forecast

Next quarter’s sales forecast for PROK is MXN 2.32M with a range of MXN 0 to MXN 3.72M. The previous quarter’s sales results were MXN 2.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PROK Stock Forecast FAQ

What is MX:PROK’s average 12-month price target, according to analysts?
Based on analyst ratings, ProKidney’s 12-month average price target is Mex$116.51.
What is MX:PROK’s upside potential, based on the analysts’ average price target?
ProKidney has 368.67% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ProKidney a Buy, Sell or Hold?
ProKidney has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 2 hold ratings and 1 sell ratings.
What is ProKidney’s share price target?
The average share price target for ProKidney is Mex$116.51. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$225.50, and the lowest forecast is Mex$18.79. The average share price target represents a 368.67% increase from the current price of Mex$24.86.
What do analysts say about ProKidney?
ProKidney’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of ProKidney?
To buy shares of MX:PROK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.